Go to the id21 home page   ID21 - communicating development research
Health
 
Search the whole id21 database
 

Help page and other search methods
    id21 Health
  Health systems
and economics
  Non-communicable
diseases
  Infectious
diseases
  HIV/AIDS
  Sexual and
reproductive health
  Maternal health
  Child health
  Environmental
health
 
    id21 Global Issues
 
    id21 Education
 
    id21 Urban Development
 
    id21 Natural Resources
 
    id21 Rural Development
 
    id21 Home page
 
    Gender and Violence in African Schools
 
    id21 Publications
 
    id21 Viewpoints
 
    About id21
 
    Links
 
    Contact id21
 
    id21News
 
    id21 Insights
 
    id21 Media
 
     
Far-fetched? Does travelling for treatment increase TB mortality risks?

The mortality rate for patients using a tuberculosis (TB) treatment programme in the Northern Province of South Africa is relatively high (12 percent). Is this related to the distance that patients have to travel for treatment? Researchers from the University of the North and Jane Furse Memorial Hospital, South Africa, and King's College Hospital, UK, address this question.

DOTS (directly-observed treatment, short-course) is the WHO-recommended strategy for TB treatment. There is a consensus that TB care should be integrated into general health services. But there is debate about how far diagnosis and treatment should be decentralised into primary healthcare. In this DOTS-based TB programme in a resource-poor setting, diagnosis and intensive phase treatment take place in the district hospital. Treatment then continues through directly observed therapy supervised by community volunteers.

The study involved four general hospitals in three health districts. Patients were classified into four groups depending on how far they lived from the hospital: up to 20 km, 20 - 40 km, 40 - 60 km and more than 60 km. The study found that:

  • Of 1187 patients who started TB treatment in the hospitals, 74 percent were known to be alive at the end of treatment, whereas 13 percent had died.
  • 91 percent of patients live within 60 km of the hospital they attend for treatment. The estimated median distance travelled is 28 km.
  • There is an increased risk of dying only for those patients living more than 60 km from the hospital.
  • Many patients who travel more than 60 km bypass hospitals nearer their home. The reasons for this are unclear.

Important features of the DOTS strategy for treatment of TB include:

  • diagnosis and management based on the results of sputum smear microscopy
  • use of standardised drug treatments that depend on the clinical setting and sputum results
  • systems for recording and reporting the outcome of treatment.

It is particularly difficult to follow these guidelines in primary healthcare settings where there are no microscopes, poor transport systems and no doctors, and where nurses have many other responsibilities.

TB mortality is high in this population, even amongst those living closest to the hospital. These results suggest that moving the diagnosis of TB from the hospitals to primary healthcare clinics may not reduce the numbers of deaths from TB in rural South Africa.

Source(s):
'Is the distance a patient lives from the hospital a risk factor for death from tuberculosis in rural South Africa?', International Journal of Tuberculosis and Lung Disease 6 (2): 1-6, by R. Barker, M. Nthangeni and F. Millard, 2002

Funded by: TB Alert

id21 Research Highlight: 25 July 2002

Further Information:
Jack Barker
King's College Hospital
Bessemer Road
Camberwell
London
UK

Tel: +44 (0)20 7346 3165
Fax: +44 (0)20 7346 3589
Contact the contributor: jack.barker@kingshc.nhs.uk

King's College Hospital, London

Other related links:
See id21's collection of links relevant to infectious diseases.

Views expressed on these pages are not necessarily those of DFID, IDS, id21 or other contributing institutions. Unless stated otherwise articles may be copied or quoted without restriction, provided id21 and originating author(s) and institution(s) are acknowledged.

Copyright © 2007 id21. All rights reserved.

Week beginning Monday 21st July 2008
FREE Information Delivery services from id21:
Get updates by email: id21 news
Insights: research digests
Contact id21


id21 is funded by the UK Department for International Development www.dfid.gov.uk
id21 is one of a family of knowledge services at the Institute of Development Studies www.ids.ac.uk at the University of Sussex www.sussex.ac.uk
IDS is a charitable company, No. 877338. id21 is a www.oneworld.net partner and an affiliate of
www.mediachannel.org

 

 

Go to the King's College Hospital, London site.